ERBB2 and breast carcinoma: Gene expression profiling pioneered by Perou et al. and Sorlie et al. showed that breast cancer can be reliably reclassified into five major subtypes (luminal A, luminal B, HER2/neu, basal-like, and normal breast-like) based on gene expression patterns from the intrinsic gene set [12], [13].